1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with diazoxide in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (diazoxide) | Trials (diazoxide) | Recent Studies (post-2010) (diazoxide) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 2,923 | 86 | 445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egido, J; Rivera, F; Sánchez-Crespo, M; Sancho, J | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and diazoxide
| Article | Year |
|---|---|
The effect of the injection of a synthetic platelet-activating factor (PAF-acether) on the fate of IgG aggregates in mice.
Topics: Animals; Antigen-Antibody Complex; Blood Volume; Diazoxide; Female; Humans; Immunoglobulin G; Male; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Platelet Activating Factor; Protein Denaturation; Tissue Distribution | 1982 |